Latest News



October 31, 2019 0

PatientConnect Video was launched by Healthgrades earlier this month to provide not only education video programming about specific health conditions, but to then connect patients with qualified, local specialists. According to the news release, “PatientConnect Video eliminates the uncertainty for patients who don’t know where to access care.”

Coupling proprietary AI technology with their innovative solution suite, this online video solution provides content along with relevant healthcare provider information. “For example, patients watching video content about rheumatoid arthritis are dynamically provided with listings of rheumatologists closest to their location along with the physicians’ accepted insurance, patient reviews, contact information and more.”

According to John Mangano, Senior Vice President, Business Intelligence for Healthgrades, this takes things a step further than the usual ‘ask your doctor for more information’ instruction typically found in ads by actually “helping the patient find their doctor. After viewing an ad online, Healthgrades delivers individually localized contact information, along with patient reviews of the provider, so each patient can connect with the right practitioner.”

admin


September 25, 2019 0

Sponsored Content

I know the pain of losing a loved one to opioid addiction. My family continues to grieve the loss of an incredible young man who, after an awful car accident, began a decade-long battle against addiction to his prescribed painkillers. Three years ago, he lost that battle.

Countless other families have experienced similar losses due to our nationwide opioid crisis. According to the Department of Health and Human Services (HHS), more than 130 people die from opioid overdoses every day. It’s a devastating epidemic that impacts people of any age and from all walks of life.

To help combat opioid addiction, PatientPoint® collaborated with Shatterproof – a nonprofit organization focused on ending the stigma of addiction and improving addiction treatment – to create a powerful opioid education program at the point of care. It launched nationwide in October 2017 across the digital PatientPoint engagement platform, reaching an estimated 15 million patients and caregivers each month in waiting rooms, exam rooms, and in the physician back office. The content is designed to increase the awareness of opioid addiction and encourage doctor-patient discussions about other treatment options.

And the best news is, it is working and we are making a difference. An independent analysis by Symphony Health revealed that each of the 20,793 physicians who had the education program in their practices distributed 142 fewer opioid prescriptions over the eight-month study period than closely matched, non-participating physicians. That adds up to nearly 3 million fewer pills prescribed. If that doesn’t prove the effectiveness of messaging to physicians and patients at the point of care, I don’t know what will.

I often talk about the power of messaging at the point of care, but the results of PatientPoint-Shatterproof campaign really drive it home. I encourage you to read the case study for more details about this fantastic campaign and its impact on the fight against opioid addiction. You can find here.

Linda Ruschau


September 25, 2019 0

Sponsored Content

In pharmaceutical marketing circles, we hear sporadic boasts of a successful social campaign, award-winning content marketing, or insights drawn from a patient community platform. The ambitious brand manager takes these case studies back to the conference room, ready to formulate a new playbook, only to be overwhelmed by the complexities of operating in our highly regulated industry.

Progressive brand strategies shouldn’t be devised to win awards or dominate the marketing trades, but if done well, they certainly deserve accolades. More importantly, meeting your patients wherever they are while offering them interactive content, and adapting your message to service their needs, paves the road to better patient outcomes and higher return-on-investment.

Merck’s VERSED campaign is a great example of activating the system described above, to raise awareness around HPV vaccination. VERSED combines content marketing (versedhpv.com), with short form social posts, interactive questions, and community guidelines for adverse event reporting.

While the campaign clearly put patients first, Merck and Klick Health also won the industry recognition they deserved.

Pharmaceutical campaigns that try to combine cutting-edge marketing technologies are often derailed by the breadth of stakeholders involved in the process. To limit disruption in creativity and execution, marketers should seek out cross-discipline solution providers, who can fast track the process. In its broader framework, The Tylt has been recognized as a pioneer in this space and the applications for healthcare are inspiring.

The Tylt is the fastest growing social polling and opinion platform on the web helping marketers create conversation, understand sentiment, and activate on vote-based data. Using patented technology, The Tylt collects opinions and relative influence data from our site and social channels in real-time. In partnership with brands, The Tylt can help achieve awareness and engagement goals by creating new content or reformatting current content for maximum interaction. Informed by voting behavior, marketers can extend the impact of a Tylt campaign by messaging audiences based on the vote they made.

For healthcare campaigns, the process begins with locating the right patient and encouraging them to share their opinion on a personally meaningful health topic. Patient advocacy becomes democratized when declared sentiments, informed by supporting evidence, are shared socially. By bringing structure to health conversations as they trend across social, patient insights can be identified and addressed in the next wave of interactive content, positioning the brand as a partner in the journey to better health.

For example, a multiple sclerosis brand may want to initiate patient interactions with a simple question: “To combat cognitive fatigue, what game do you prefer to play to keep your mind active?”

Answering that question in hashtag form (#SudokuForMS or #CrosswordForMS) creates a unique campaign identifier that allows for insights collection, as votes are shared across social media. The original question reaches an MS population with standard targeting models, whether they receive the poll on social media, as a display ad, or as a polling widget on brand.com or our partnered sites. While the brand itself may display sponsorship logos or embed assets throughout the campaign, the campaign value multiplies over time, by engaging patients after they’ve provided self-reported data.

The pharmaceutical marketing industry’s reliance on traditional media has reached the point of stagnation. With TV, print, or digital display, the highest spender wins share-of-voice, and if the product is effective, it gains market share. The only way to disrupt this model is to stay focused on innovations that add value through personalization, platform agnosticism, and a relentless focus on patient interaction.

To learn more about activating The Tylt in your next pharmaceutical marketing campaign, contact Jason Lotkowictz (JasonL@Advance360.com).

Jason Lotkowictz


September 25, 2019 1

In its ongoing commitment to raising awareness of mental health conditions and treatments and to help the millions of suffering adults, Allergan launched a new campaign for VRAYLAR earlier this month. To represent the ups and downs of mood swings associated with bipolar I disorder, the campaign showcases a woman viewing various episodes of her life as she rides up and down in a shaky elevator.

In “The Ups and Downs Campaign,” upon entering the elevator and pressing the button to her floor, all of the button lights begin to flicker rapidly. The elevator plummets down, with the doors then opening to show her crying on the edge of her bed, before surging back up high, where the doors open on a scene of her arguing with a man. The elevator screen then shows the arrows pointing in both directions, as the doors open to reveal her clothes shopping in a panicked state. After taking VRAYLAR, the elevator ride steadies before stopping in her current life moment where she cleans up the mess in her bedroom, and then takes a smooth elevator ride to meet her date in the lobby.

The creative was shaped by “insights and anecdotes shared by” bipolar I disorder patients, according to the public relations team. “Using physical metaphors taken from how patients describe the condition,” this illustration helps describe the mood episodes as well as the transitions between, covering the full spectrum of bipolar I symptoms: depression, mixed episodes, and mania. The next stage of this campaign will introduce another visual, “inspired by real analogies real patients made about how the ups and downs of bipolar can feel. The intention is to help more people who may be living with the condition recognize the symptoms, and talk to their doctors to see appropriate treatment.”

The campaign includes in-network and cable spots, running in all time periods of the day but with a particular attention to specific shows. Print and newly designed website companion elements launched mid-month. BBDO created the ad; BCW supports the PR and strategic communications efforts for the brand.

admin


September 25, 2019 0

Three new member companies have joined the Point of Care Communication Council (PoC3), as announced this month: CoverWrap Communications, Rx EDGE Media Network, and Targeted Media Health (a division of Meredith Corporation). In addition to “[helping] influence and amplify the future of POC marketing. In the near term, they plan to immerse into the PoC3 Verification & Validation Guidance effort and the establishment of measurement best practices.”

David M. Kenyon, CEO at CoverWrap Communications, Nate Lucht, President & CEO of Rx EDGE and Leverage Point Media, John Kenyon, VP and Managing Director with Targeted Media Health, were all in agreement as they shared their enthusiasm in joining PoC3 and helping to advocating for and strengthening the point of care space, as per the news release.

Karen Newmark, Executive Director with PoC3, shared how this continued expansion helps the association lead the progress: “PoC3 has grown tremendously over the past year, and we anticipate the growth increasing in 2020. We expect to see different types of companies, all with common interest in the PoC3 mission, wanting to build on the unprecedented momentum in the POC channel.”

Click here to read the complete news release and full team member statements: https://www.poc3.org/post/point-of-care-communication-council-welcomes-three-new-members.

admin


September 24, 2019 0

The custom campaign, In These Rooms, launched this month to help transform the point of care space to a more empathetic “moments of care” image. Created by Outcome Health, a 90-second video was released which portrayed life-changing moments that patients and caregivers experience in waiting rooms and exam rooms. According to a news release, In These Rooms depicts “raw, authentic emotion” to create a shift in mindset when it comes to healthcare content in these locations and channels. The long-form video will be complemented by shorter spots – distributed via selected healthcare trade support – as well as a social media campaign.

To provide a well-rounded representation of potential patient and caregiver experiences with their healthcare professionals, the creative includes: “a waiting room, a pediatrician visit for an asthma check-up, an OB-GYN ultrasound room to hear a baby’s first heartbeat, a standard exam room for a long-overdue physical, and a doctor’s office to learn about treatment results.”

Matt McNally, CEO of Outcome Health and DTC Innovator honoree, stated in the news release: “In These Rooms challenges all pharma marketers and their agency partners to think differently about point of care and is the first step in our commitment to the ongoing understanding of the needs in this space. Today, we call on our industry to create content and experiences that wrap patients with empathy, education and support at the ‘moments of care’ when they are most vulnerable and need it most.”

admin


August 28, 2019 0

 

It’s been five years since Gartner called Prescriptive Analytics “the final frontier for Big Data, where companies can finally turn the unprecedented levels of data into powerful action.” Will prescriptive analytics be the final frontier for health marketers?

Pharma Marketers’ Analytics Adoption Curve

Let’s start by understanding where pharma marketing is on the analytics adoption curve.

  • Do you retroactively analyze what happened with your media campaigns? If YES, you’re using Descriptive Analytics.
  • Do you evaluate, in a deliberate and controlled fashion, why it happened? If YES, you’re using Diagnostic Analytics.
  • Do you have enough data and intelligence to predict what is most likely to happen? If YES, you’re using Predictive Analytics.
  • Do you use logic and math to decide how to make it happen? If YES, you’re using Prescriptive Analytics.

While almost all pharma marketers are using Descriptive and Diagnostic Analytics to a certain extent to measure and evaluate their media campaigns, no one to my knowledge is using Predictive and Prescriptive Analytics approaches with measurable success in health. The approach has been used successfully in mass brands for marketing, and in pharma for supply chain management, customer service modeling, and even clinical trial management, but not for marketing and media.

What Prescriptive Analytics Could Look Like

And yet we talk about prescriptive analytics because the promise is extraordinary. Let’s imagine the possibility.

For example, every month nearly 100 million people visit Healthline. With big data models, we would be able to predict the condition profiles of our readers, what content they’re going to read, what ads they’re going to click on, and what brands they will ultimately buy. With that information, we could use AI in real time to individualize and personalize the experience for each reader and determine which ad unit(s) to show them, in which platform (site, social network, newsletter), and in what order, to influence specific behaviors such as visiting a particular website page, and delivering a specific outcome like a new brand start.

Sponsoring brands could manage the reach of their ad campaigns and forecast the increased demand generated by their ad spend far more accurately. The prospect is enticing.

Limitations of Prescriptive Analytics in Health Marketing

Before we fully embrace the allure, let’s recognize some of the limitations of predictive analytics in health marketing.

  • The scale of the data just doesn’t exist. Sure, if we’re talking about a condition like flu, which affects large swaths of the world’s population, we may be able to build models that work. But what about advanced metastatic breast cancer? Or ankylosing spondylitis? The numbers of cases of these conditions are small, so the predictive power is far from confident and the models fall apart.
  • Media campaigns don’t really relate to each other. To get the historical learning at scale, we’d need to combine the learning across all media campaigns, across all brands, even across all conditions. But brands are different. Insights are different. Messages and levers are different. The experience from one campaign doesn’t apply to another, even though the holistic experience can yield powerful insights.
  • The patient journey is truly individual. Perhaps, with really big data sets, we can find demographic or behavioral markers that correlate with condition profiles, advertising sensitivity, or likelihood to get on brand. But the correlation won’t be high, and won’t necessarily portend future behavior. It’s because health is multifactorial and every person is truly unique. Not everyone with advanced metastatic breast cancer is the same. They live under different economic conditions, social determinants, value systems, and risk curves. There may exist a handful of people who mimic similar behaviors, but never segments large enough to truly validate the effort.
  • Last but not least, patient privacy protection limits widespread use of patient data. Industries leveraging prescriptive analytics with machine learning and artificial intelligence have significantly fewer barriers than health and pharma marketers. HIPAA makes data matching and outcomes-based analysis extremely challenging. Add to that the data loss now with GDPR and CCPA, further diminishing the sample sizes available for testing and optimizing, and making universal recommendations impossible.

How Pharma Can Be Data-Driven

Instead of chasing big data models, marketers can be predictive and prescriptive with their media campaigns by using descriptive and diagnostic data combined with human computing: human discernment, sensitivity, and gumption.

Here are our four principles:

  1. Live by the data. Continue to invest in machines to run the decision rules behind your dashboard, alerting you when a campaign is in the “red” or “green” zone. But make sure you have empathetic humans available to receive those alerts and act on them.
  2. Surround yourself with a team of competitive hard-core analysts. They’re hard-wired to go beyond current standards. They’re your human engine, to fine-tune future results and predict future results.
  3. Be smarter about how you use historical data. Ask “What worked?” Also, scenario plan by asking “What could work better?” to understand and perfect campaign effectiveness. Be strategic. Start with the end goal in mind, test and experiment, and deftly piece together the answers to “how” and “why.”
  4. Optimize actively, not passively. When your agency or partner presents their optimization approach, don’t gloss over that section. Approach optimization as a critical strategic lever. Build rapid review cycles, and learn and codify that learning everyday.

Prescriptive analytics gives us an ideal to aspire to, but not something we can realistically participate in today. However, we can take the key principles from that ideal and incorporate them in the way we run our campaigns. We can adhere to scientific rigor, transparency, and connecting humans to the numbers to rethink and refine campaigns. For now, it may not be a golden goose, but it’s not an empty promise either.

 

Jennifer Loga


August 28, 2019 0

The Department of Health and Human Services (HHS) filed a notice of appeal on August 21st in response to the July ruling that blocked price disclosure in TV drug advertising. Handed down by Judge Amit Mehta of the US District Court, he ruled against the measure, stating: “HHS lacks the statutory authority under the Social Security Act to adopt the WAC [wholesale acquisition cost] Disclosure Rule.” At the time of his decision, HHS seemed to hint that they were going to file an appeal, saying they would “work with the Department of Justice on next steps related to the litigation.”

In May of this year, HHS outlined their plan for the WAC Disclosure Rule. Amgen, Merck, and Eli Lilly, joined by the Association of National Advertisers, filed a lawsuit in mid-June to prevent it from going into effect. Judge Mehta sided with the plaintiffs in early July. The price disclosure rule for TV advertising would apply to drugs with a list price of $35 or higher for a 30-day supply.

admin


August 28, 2019 0

Ogilvy Health, a part of Ogilvy, has promoted seven creative team members in the agency’s New Jersey and New York offices. Expressing her excitement for the department’s growth was Ogilvy Health North America’s Chief Creative Officer, Samantha Dolin: “I couldn’t be more thrilled to see this group acknowledged for their respective talents and collective leadership. Their brilliant contributions every day help to elevate the entire Ogilvy Health team and the new roles they are taking on will allow their impact to be felt more broadly across so many of our key accounts. As they continue to drive meaningful results and delight our clients, I am looking forward to building our next creative chapter with this group of tremendously talented individuals.”

The new advancements are:

  • Mike Brune and Deborah Ciauro have been promoted to the positions of Executive Creative Directors.
  • Larry Hannon has been elevated to Senior Vice President, Creative Director.
  • Beth Elkis and George Giunta have advanced to the posts of Group Creative Directors.
  • Anita Caruso has moved to Vice President, Associate Creative Director.
  • Agnes Topor has advanced to Associate Creative Director.
Mike Brune
Deborah Ciauro
Larry Hannon
Beth Elkis
George Giunta
Anita Caruso
Agnes Topor

admin


August 28, 2019 0

HCB Health announced the hiring of ten new team members under its BioPharma division and an additional four to support the agency across all groups. Of the new hires, three will take on roles in senior management: Gabriel Cangiano, Mark Davis, and Travis Waggoner.

New BioPharma team members:

  • Denise Byrne joins as Senior Project Manager in HCB Health’s Chicago location. Denise was previously a Senior Project Manager at Havas Life Metro.
  • Leslie Calabrese joins as Assistant Account Executive in Chicago. Leslie was a Social Engagement Associate at Golin prior to this role.
  • Gabriel Cangiano serves as VP, Group Account Supervisor in Chicago. Gabriel joins from GC Healthcare Consulting, having been a Consulting Director, and InTouch Solutions, where he was a Group Account Director, HCP and Market Access.
  • Brooke Claussen is an Associate Creative Director in Chicago. Brooke was with InTouch Solutions previously as an Associate Creative Director.
  • Nick D’Amore serves as Medical Editor in West New York / New Jersey. Nick was with FCB Health as a Senior Medical Editor previously.
  • Ethan Stickle joins as Account Supervisor in Chicago. Most recently, he work for The Sandbox Agency as Account Supervisor.
  • Pooja Desai holds the role of Senior Account Executive in Chicago. Pooja was a Senior Account Executive with EVERSANA previously.
  • Christine Mavridis (Chris Mav) is an Associate Creative Director in the Raleigh-Durham, North Carolina office. Most recently, Chris was a Group Copy Supervisor with McCann Health.
  • Julyna Moore is a Senior Art Director in Chicago, having previously held the Senior Art Director role at AbelsonTaylor.
  • Ruth Nobile joins as an Account Executive in the Austin location. Most recently, Ruth, a postdoctoral marketing fellow, was with Bayer Pharmaceuticals in US Oncology Marketing.

Supporting the entire agency:

  • Cody Morris is now an Associate UX (user experience) Designer, working in the Austin location. He was previously a contract / freelance graphic designer.
  • Mark Davis holds the role of SVP Multichannel Delivery in New Jersey. Prior to that, he was a healthcare digital marketing consultant, and was with Sudler & Hennessey as a SVP, Digital Strategist.
  • Travis Waggoner serves as IT Director in Austin. Travis was previously with TeamLogicIT as a Solutions Engineer / Technical Delivery.
  • Kelsi Brown joins as Director of Employee Engagement in Austin. Previously, Kelsi was a Senior HR Manager at T3.

admin